Carl Byrnes
Stock Analyst at Northland Capital Markets
(3.28)
# 835
Out of 5,182 analysts
27
Total ratings
50%
Success rate
19.29%
Average return
Main Sectors:
Stocks Rated by Carl Byrnes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Initiates: Outperform | $10 | $4.11 | +143.31% | 1 | Mar 5, 2026 | |
| BWAY BrainsWay | Maintains: Outperform | $9.5 → $12 | $17.17 | -33.02% | 5 | Nov 12, 2025 | |
| SNWV SANUWAVE Health | Initiates: Outperform | $55 | $15.57 | +253.24% | 1 | Sep 3, 2025 | |
| BLFS BioLife Solutions | Maintains: Outperform | $28 → $31 | $22.08 | +40.43% | 2 | Jan 8, 2025 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $13 | $4.43 | +182.17% | 1 | Oct 25, 2024 | |
| MDAI Spectral AI | Initiates: Outperform | $6 | $2.31 | +159.74% | 1 | Aug 12, 2024 | |
| COCH Envoy Medical | Initiates: Outperform | n/a | $0.65 | - | 1 | Dec 21, 2023 | |
| AMRN Amarin Corporation | Maintains: Market Perform | $40 → $25 | $15.05 | +66.11% | 1 | Jul 19, 2023 | |
| CDIO Cardio Diagnostics Holdings | Initiates: Outperform | $240 | $1.83 | +13,014.75% | 1 | May 22, 2023 | |
| VTVT vTv Therapeutics | Maintains: Outperform | $60 → $80 | $30.68 | +160.76% | 4 | Aug 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $3.60 | +538.89% | 3 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $30 → $24 | $3.14 | +664.33% | 4 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $2,000 | $2.50 | +79,900.00% | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.21 | - | 1 | Sep 27, 2017 |
AVITA Medical
Mar 5, 2026
Initiates: Outperform
Price Target: $10
Current: $4.11
Upside: +143.31%
BrainsWay
Nov 12, 2025
Maintains: Outperform
Price Target: $9.5 → $12
Current: $17.17
Upside: -33.02%
SANUWAVE Health
Sep 3, 2025
Initiates: Outperform
Price Target: $55
Current: $15.57
Upside: +253.24%
BioLife Solutions
Jan 8, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $22.08
Upside: +40.43%
TriSalus Life Sciences
Oct 25, 2024
Initiates: Outperform
Price Target: $13
Current: $4.43
Upside: +182.17%
Spectral AI
Aug 12, 2024
Initiates: Outperform
Price Target: $6
Current: $2.31
Upside: +159.74%
Envoy Medical
Dec 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $0.65
Upside: -
Amarin Corporation
Jul 19, 2023
Maintains: Market Perform
Price Target: $40 → $25
Current: $15.05
Upside: +66.11%
Cardio Diagnostics Holdings
May 22, 2023
Initiates: Outperform
Price Target: $240
Current: $1.83
Upside: +13,014.75%
vTv Therapeutics
Aug 17, 2022
Maintains: Outperform
Price Target: $60 → $80
Current: $30.68
Upside: +160.76%
Jul 26, 2021
Initiates: Outperform
Price Target: $23
Current: $3.60
Upside: +538.89%
May 5, 2021
Maintains: Market Perform
Price Target: $30 → $24
Current: $3.14
Upside: +664.33%
Oct 22, 2018
Initiates: Outperform
Price Target: $2,000
Current: $2.50
Upside: +79,900.00%
Sep 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $1.21
Upside: -